Follow the people · Insider
Elaine Mary Shannon
Elaine Mary Shannon files insider transactions with the SEC as a pres., global supply & quality of Takeda Pharmaceutical Co (TAK). We hold 2 disclosed purchases and sales filed since 6 July 2026, 2 of them in the last 90 days.
- Files forTAK
- Disclosed buys and sells2 in all, 2 in the last 90 days
- Last disclosure12 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 1 July 2026 — 11 August 2026Pres., Global Supply & Quality · Takeda Pharmaceutical Co (TAK)3 Form 4 lines · source: SEC Form 4
Everything they disclosed
3 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 20,363 shares of Takeda Pharmaceutical CoSEC Form 412 August 2026American Depositary Shares · traded 11 August 2026 · filed 12 August 2026
- ▼ sold on the open market 3,978 shares of Takeda Pharmaceutical CoSEC Form 412 August 2026American Depositary Shares · traded 10 August 2026 · filed 12 August 2026
- was granted 30,094 shares of Takeda Pharmaceutical CoSEC Form 46 July 2026American Depositary Shares · traded 1 July 2026 · filed 6 July 2026
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.